Skip to main content

Table 1 Participating hospitals and wards and recruitment (ITT [PP])

From: Implementation of a nurse-led self-management support intervention for patients with cancer-related pain: a cluster randomized phase-IV study with a stepped wedge design (EvANtiPain)

Hospital

Ward

Ordera

Main medical field

% oncology patientsb

sizec

N IG ITT (PP)d

N CG ITT (PP)e

H 1

W 9f

8

Gynecology

40

25

0

3

H 1

W 10

3

Oncology/Internal medicine

70

21

3

1

H 1

W 11

14

Internal Medicine/Oncology

40

20

0

6

H 1

W 12

1

Pneumology

45

22

3

1

H 1

W 13

12

Pneumology

40

21

0

1

H 2

W 14

17

Internal Medicine/Oncology

60

27

0

5

H 2

W 15

9

Internal Medicine/Oncology

50

27

0

3

H 2

W 16

10

Internal Medicine/Oncology

50

27

0

5

H 2

W 17

2

Oncology/Hematology

98

13

4 (3)

2 (3)

H 3

W 1

15

Surgery

2g

32

0

1

H 3

W 2

5

Surgery

70

23

9

4

H 3

W 3

16

Oncology

99

25

0

17

H 3

W 4

11

Gynecology

95

20

8 (6)

21 (23)

H 3

W 5

13

Ear nose and throat

30

24

1

3

H 3

W 6

6

Ear nose and throat

30

24

0

6

H 3

W 7

7

Radiotherapy

98

36

16 (11)

9 (14)

H 3

W 8

4

Radiotherapy

99

12

17 (9)

4 (12)

  1. aOrder of implementation, each step/sequence between implementations was ~ 24 days
  2. bThis assumed rate was assessed in an interview with head nurses prior to recruitment of each ward
  3. cNumber of beds
  4. dIG: intervention group, ITT: intention to treat approach - analyzing each patient after implementation of the intervention (PP: per protocol approach - analyzing each patient who received the intervention n in brackets)
  5. eCG: control group, ITT: intention to treat approach - analyzing each patient before implementation of the intervention (PP: per protocol approach - analyzing each patient who did not receive the intervention n in brackets)
  6. fAfter recruitment and randomization, an organizational change caused that this ward did not have many oncology patients any more. At inclusion, this ward would have had 50% oncology patients